𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types

✍ Scribed by E. K. Perry; C. J. Smith; J. A. Court; R. H. Perry

Publisher
Springer
Year
1990
Tongue
English
Weight
631 KB
Volume
2
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cholinergic and other neurotransmitter m
Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies
✍ Paul T. Francis; Elaine K. Perry πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 75 KB

It is now 30 years since the beginning of intensive efforts to understand the neurotransmitter biochemistry of dementia as exemplified by Alzheimer's disease and such studies have led to the development of rational treatment strategies, which are continuing to benefit patients. However, as studies b

Comparison of dementia with Lewy bodies
Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia
✍ Enrique Noe; Karen Marder; Karen L. Bell; Diane M. Jacobs; Jennifer J. Manly; Ya πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

## Abstract We compared the clinical and neuropsychological pattern of dementia with Lewy bodies (DLB) to Alzheimer's disease (AD) and Parkinson's disease with dementia (PD‐d). Sixteen patients clinically diagnosed with DLB were compared with two groups of patients with PD‐d (n = 15) and AD (n = 16

Pentagon drawing and neuropsychological
Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia
✍ Francesca Cormack; Dag Aarsland; Clive Ballard; Martin J. TovΓ©e πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

## Abstract ## Objectives Early and accurate diagnosis of Dementia with Lewy Bodies (DLB) to allow the appropriate clinical treatment is a priority, given reports of severe neuroleptic sensitivity and a preferential response to cholinesterase inhibitors in these patients. There have been suggestio